TOP2A and neoplasm: The resulting data showed a significant decrease in tumor weight and volume after the treatment by APAN or/and ETO, which may be due to the ability of APAN to intercalate into GC-rich sequences and encroach with the catalytic TOP2 activity and then induce apoptosis and stop cell cycle in the malignant cells.